Last updated: June 2, 2026
ERMEZA suppliers: Which companies manufacture and supply the drug and its key components?
Executive summary: ERMEZA is an ammonium chloride oral solution product. The supplier landscape depends on the exact presentation and package (strength and size) because manufacturing and packaging contractors can vary by lot, market, and contract terms. Without the specific ERMEZA listing (strength, NDC, labeler, and dosage form) and the public FDA/Orange Book entry that matches that exact product, a complete, accurate mapping of manufacturers, packagers, and API/excipient suppliers cannot be produced.
What company makes ERMEZA (ammonium chloride oral solution) and who is the labeler on the FDA listing?
Answer (data requirement): A definitive supplier list requires the FDA SPL/NDC labeler tied to the exact ERMEZA product (strength, dosage form, package). Supplier entities typically include:
- Labeler (applicant/holder on the FDA listing)
- Manufacturer (site listed for drug product)
- Packaging site(s)
- Distributor/secondary packer, if listed
Why this matters for “suppliers”: In FDA supply-chain terms, “supplier” can mean different roles:
- drug product manufacturer (finished dosage site)
- packaging and labeling contractor
- API manufacturer (if separately listed in regulatory filings or DMFs)
- excipient or component suppliers (usually not fully exposed in public Orange Book)
Which ERMEZA manufacturers are listed for the finished drug product site-by-site?
Answer (data requirement): Finished dose sites are enumerated in the FDA product listing that corresponds to the specific NDC. Public registries commonly show:
- drug product manufacturing location(s)
- packaging location(s)
- labeling/testing site(s) where disclosed
A complete supplier table must be built from the correct ERMEZA NDC/SPL record.
Are there separate packaging contractors for ERMEZA (oral solution)?
Answer (data requirement): Many oral solution SKUs have separate packaging/labeling sites. The only reliable way to identify “packager suppliers” is to pull the FDA listing for the specific package NDC and extract the listed packaging facility fields.
What is the API supplier for ERMEZA ammonium chloride oral solution?
Answer (data requirement): API suppliers are not consistently enumerated in the Orange Book for older or simpler chemical products, and they often sit behind:
- DMFs (Drug Master Files)
- confidential disclosure in regulatory submissions
- general API sourcing that does not appear in public product listings
A correct API supplier mapping requires the exact Orange Book entry and any linked public DMF references tied to the ERMEZA applicant.
What excipient or component suppliers are associated with ERMEZA formulation?
Answer (data requirement): Excipient vendors typically are not listed in public FDA structures for finished products. Some excipient supplier data can appear indirectly in:
- manufacturing descriptions in certain regulatory documents
- vendor qualification documentation (not public)
- limited public labeling content (usually only ingredient names, not vendor identities)
A supplier list of excipient vendors cannot be generated accurately without the specific publicly disclosed sources for that ERMEZA product.
What do Orange Book and FDA SPL filings show for ERMEZA labeler and manufacturer?
Answer (data requirement): Orange Book and FDA SPL provide the authoritative public mapping from:
- product identifier (NDC) to
- labeler (applicant) and
- disclosed manufacturing/packaging sites
A supplier answer must cite and tabulate those entries for the correct ERMEZA SKU.
How do ERMEZA supply chain suppliers differ by NDC, strength, and package size?
Answer (data requirement): Multiple NDCs can exist for the same brand name with different:
- concentrations
- fill volumes
- vial/bottle sizes
- labeler/applicant assignments
Each can map to different contract manufacturing and packaging sites.
Which companies supply ERMEZA to wholesalers, hospitals, and pharmacies?
Answer (data requirement): Public FDA listings typically do not fully expose downstream distribution supplier structures. Wholesaler distribution is handled through:
- wholesaler networks (secondary distribution)
- direct distribution agreements
- GPO/channel contracts
Those are often not publicly itemized by product in a way that permits a complete supplier list.
Key Takeaways
- A complete, accurate “ERMEZA suppliers” map requires the exact ERMEZA product listing (NDC/strength/dosage form) because manufacturer and packager sites can vary by SKU.
- Public FDA/Orange Book data can support a labeler and site-level drug product/packaging supplier table when matched to the correct ERMEZA listing.
- API and excipient vendor supplier names often are not fully public and cannot be reliably enumerated without the specific publicly disclosed entries tied to that SKU.
FAQs
- How can I identify the ERMEZA drug product manufacturer site from FDA data?
- Does ERMEZA have different manufacturers for different NDCs?
- Is ammonium chloride API supplier information publicly available for ERMEZA?
- What packaging sites are listed for ERMEZA oral solution products?
- Can Orange Book listings show the applicant/holder for ERMEZA?
References
- FDA Orange Book. (n.d.). Drug Products (Orange Book). U.S. Food and Drug Administration.
- FDA SPL (Structured Product Labeling). (n.d.). SPL data for marketed products. U.S. Food and Drug Administration.
